Adjuvant Therapy for Esophageal Squamous Cell Carcinoma
Adjuvant therapy for completely resected esophageal squamous cell carcinoma is less commonly applied in clinical practice than neoadjuvant therapy, but it plays a substantial role in improving survival for esophageal cancer patients. This article presents a concise re-view of the evidence regarding...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Korean Society for Thoracic and Cardiovascular Surgery
2020-08-01
|
| Series: | Korean Journal of Thoracic and Cardiovascular Surgery |
| Subjects: |
| _version_ | 1819083244674482176 |
|---|---|
| author | Jong-Mu Sun |
| author_facet | Jong-Mu Sun |
| author_sort | Jong-Mu Sun |
| collection | DOAJ |
| description | Adjuvant therapy for completely resected esophageal squamous cell carcinoma is less commonly applied in clinical practice than neoadjuvant therapy, but it plays a substantial role in improving survival for esophageal cancer patients. This article presents a concise re-view of the evidence regarding adjuvant therapy for esophageal squamous cell carcinoma and future directions, particularly immunotherapy. |
| first_indexed | 2024-12-21T20:29:29Z |
| format | Article |
| id | doaj.art-62b5838f42fd4c739ee4a52484ce8283 |
| institution | Directory Open Access Journal |
| issn | 2233-601X 2093-6516 |
| language | English |
| last_indexed | 2024-12-21T20:29:29Z |
| publishDate | 2020-08-01 |
| publisher | Korean Society for Thoracic and Cardiovascular Surgery |
| record_format | Article |
| series | Korean Journal of Thoracic and Cardiovascular Surgery |
| spelling | doaj.art-62b5838f42fd4c739ee4a52484ce82832022-12-21T18:51:17ZengKorean Society for Thoracic and Cardiovascular SurgeryKorean Journal of Thoracic and Cardiovascular Surgery2233-601X2093-65162020-08-0153416817110.5090/kjtcs.2020.53.4.168Adjuvant Therapy for Esophageal Squamous Cell CarcinomaJong-Mu Sun0https://orcid.org/0000-0001-9683-4111Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, KoreaAdjuvant therapy for completely resected esophageal squamous cell carcinoma is less commonly applied in clinical practice than neoadjuvant therapy, but it plays a substantial role in improving survival for esophageal cancer patients. This article presents a concise re-view of the evidence regarding adjuvant therapy for esophageal squamous cell carcinoma and future directions, particularly immunotherapy.adjuvant therapyesophageal neoplasmsneoadjuvant therapyimmuno-therapy |
| spellingShingle | Jong-Mu Sun Adjuvant Therapy for Esophageal Squamous Cell Carcinoma Korean Journal of Thoracic and Cardiovascular Surgery adjuvant therapy esophageal neoplasms neoadjuvant therapy immuno-therapy |
| title | Adjuvant Therapy for Esophageal Squamous Cell Carcinoma |
| title_full | Adjuvant Therapy for Esophageal Squamous Cell Carcinoma |
| title_fullStr | Adjuvant Therapy for Esophageal Squamous Cell Carcinoma |
| title_full_unstemmed | Adjuvant Therapy for Esophageal Squamous Cell Carcinoma |
| title_short | Adjuvant Therapy for Esophageal Squamous Cell Carcinoma |
| title_sort | adjuvant therapy for esophageal squamous cell carcinoma |
| topic | adjuvant therapy esophageal neoplasms neoadjuvant therapy immuno-therapy |
| work_keys_str_mv | AT jongmusun adjuvanttherapyforesophagealsquamouscellcarcinoma |